According to a CNN article, the FDA announced Monday that they would be increasing their recall list of heart medications that contain the ingredient valsartran.
Valsartran is a chemical widely used in medications that treat issues such as heart failure or blood pressure problems. It has been discovered recently however that some medications containing valsartran, also contain a substance known as N-nitrosodimethylamine or NDMA which has been declared to be a possible carcinogen by the Environmental Protection Agency (EPA). The pharmaceutical companies whose medications are currently listed in the recall are as follows:
AvKare (Teva/Actavis) and (Hetero/Camber)
A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco)
Bryant Ranch Prepack Inc, (Teva/Actavis),
Hetero Labs (labeled as Camber Pharmaceuticals Inc.),
H J Harkins Co.,
Northwind Pharmaceuticals (Teva/Actavis),
NuCare Pharmaceuticals Inc. (Prinston/Solco),
Preferred Pharmaceuticals Inc. (Hetero/Camber)
Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC),
Proficient Rx LP
Remedy Repack, Remedy Repack (Prinston/Solco),Remedy Repack Inc. (Hetero/Camber), RemedyRepack Inc. (Torrent),
Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis) and Torrent Pharmaceuticals Limited.